The Corrosive Esophagitis (Erosive Esophagitis) drugs in development market research report provides comprehensive information on the therapeutics under development for Corrosive Esophagitis (Erosive Esophagitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Corrosive Esophagitis (Erosive Esophagitis). Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Corrosive Esophagitis (Erosive Esophagitis) and features dormant and discontinued products.
GlobalData tracks eight drugs in development for Corrosive Esophagitis (Erosive Esophagitis) by ten companies/universities/institutes. The top development phase for Corrosive Esophagitis (Erosive Esophagitis) is phase iii with four drugs in that stage. The Corrosive Esophagitis (Erosive Esophagitis) pipeline has eight drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Corrosive Esophagitis (Erosive Esophagitis) pipeline products market are: Daewoong, Sebela Pharmaceuticals and Luoxin Pharmaceuticals Group Stock.
The key targets in the Corrosive Esophagitis (Erosive Esophagitis) pipeline products market include Potassium Transporting ATPase Alpha Chain 1 (Gastric H(+)/K(+) ATPase Subunit Alpha or Proton Pump or ATP4A or EC 7.2.2.19), D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2), and 5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4).
The key mechanisms of action in the Corrosive Esophagitis (Erosive Esophagitis) pipeline product include Potassium Transporting ATPase Alpha Chain 1 (Gastric H(+)/K(+) ATPase Subunit Alpha or Proton Pump or ATP4A or EC 7.2.2.19) Inhibitor with six drugs in Pre-Registration. The Corrosive Esophagitis (Erosive Esophagitis) pipeline products include three routes of administration with the top ROA being Oral and one key molecule types in the Corrosive Esophagitis (Erosive Esophagitis) pipeline products market including Small Molecule.
Corrosive Esophagitis (Erosive Esophagitis) overview
Erosive esophagitis is the damage caused to the tissue lining. It occurs because of the reflux of gastric contents into the stomach leading to mucosal injury. It is otherwise called as corrosive esophagitis whichis the severe form of gastroesophageal reflux disease (GERD).
For a complete picture of Corrosive Esophagitis (Erosive Esophagitis)’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
